SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer
Status:
Unknown status
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of S-1 plus oxaliplatin
combination chemotherapy based on the adverse events and survival period by performing a
phase I/II study of this combination in patients with D2 resection of gastric cancer.